Company news
Aspen Pharmacare Holdings Limited (JSE:APN) news
Aspen Pharmacare Holdings Limited news releases on 6ix. Latest, Jul 2, 2026: Aspen Pharmacare Says PIC Buys 20.1% Interest In Co
Press releases & updates
Aspen Pharmacare Says PIC Buys 20.1% Interest In Co
July 2, 2026
APN: APAC divestment boosts balance sheet strength, enabling growth and potential share buybacks
May 29, 2026
Africa CDC and Aspen Pharmacare aim to boost vaccine output in Africa
May 12, 2026
Aspen Receives Approval To Release First Commercial Batches Of Human Insulin In South Africa
May 5, 2026
Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year
March 4, 2026
Aspen Pharmacare expects Canada entry with Ozempic generic by third quarter
March 3, 2026
Aspen Pharmacare Expects HY HEPS Of 400.1 To 432.4 Cents
February 11, 2026
Goldman, Blackstone to fund $976 million loan for Aspen Pharmacare's Asia Pacific operations buyout- Bloomberg News
February 5, 2026
APN: APAC sale unlocks value, reduces debt, and shifts focus to high-growth pharma and manufacturing
January 15, 2026
South African Markets - Factors to watch on December 30
December 30, 2025
Stocks march toward best year since 2017
December 29, 2025
Aspen Pharmacare Says All Resolutions Passed At AGM
December 4, 2025
Aspen Pharmacare Says Coronation's Clients Hold 15.04% Stake In Aspen Pharmacare
November 20, 2025
South Africa's Aspen settles mRNA contract dispute for 25 million euros
October 31, 2025
Aspen wins approval to market Lilly's Mounjaro for weight loss in South Africa
October 13, 2025
APN: Commercial Pharma growth offset by Manufacturing loss; recovery expected via GLP-1 and cost actions
September 4, 2025
Aspen gets approval for Mounjaro pen in South Africa, stepping up Novo rivalry
September 3, 2025
SA's Competition Tribunal Approves Aspen Pharmacare's Deal for Ingelheim's Product Rights
July 16, 2025
SNG: South Africa: Medshield is committed to building a sustainable healthcare future
June 30, 2025
South Africa's state-owned Public Investment Corporation appoints new CEO
May 15, 2025
APN: Double-digit CER growth and strategic advances in GLP-1 and manufacturing drive strong H1 2025
March 4, 2025
APN: Revenue up 10% to R44.7bn, EBITDA up 1%, and portfolio de-risked by key acquisitions
September 4, 2024